fatty acid synthesis ACC FAS
Selected indexed studies
- New targets for NAFLD. (JHEP Rep, 2021) [PMID:34667947]
- Lipogenesis inhibitors: therapeutic opportunities and challenges. (Nat Rev Drug Discov, 2022) [PMID:35031766]
- The AMPK pathway in fatty liver disease. (Front Physiol, 2022) [PMID:36203933]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- New targets for NAFLD. (2021) pubmed
- Lipogenesis inhibitors: therapeutic opportunities and challenges. (2022) pubmed
- The AMPK pathway in fatty liver disease. (2022) pubmed
- Metabolic reprogramming of interleukin-17-producing γδ T cells promotes ACC1-mediated de novo lipogenesis under psoriatic conditions. (2025) pubmed
- Kinetic data for modeling the dynamics of the enzymes involved in animal fatty acid synthesis. (2023) pubmed
- Wnt10b Participates in Regulating Fatty Acid Synthesis in the Muscle of Zebrafish. (2019) pubmed
- Acetyl-CoA-Carboxylase 1-mediated de novo fatty acid synthesis sustains Lgr5(+) intestinal stem cell function. (2022) pubmed
- Non-Alcoholic Fatty Liver Disease. (2017) pubmed
- Oleic Acid and Hydroxytyrosol Inhibit Cholesterol and Fatty Acid Synthesis in C6 Glioma Cells. (2017) pubmed
- n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review. (2019) pubmed